Mel Mann
Patient featured in the episode who was diagnosed with chronic myeloid leukemia and shares his personal experience of participating in clinical trials and taking Gleevec.
Best podcasts with Mel Mann
Ranked by the Snipd community
28 snips
May 11, 2026 • 14min
Without this pill, lots of people would be dead
Mel Mann, a CML survivor who joined clinical trials and took Gleevec, shares his personal journey. Sydney Lupkin, an NPR pharmaceuticals correspondent, traces the drug’s discovery, rapid approval, and lasting legacy. They explore targeted therapy’s origins, dramatic patient responses, and how one pill reshaped cancer treatment.
